Cite
APA Citation
Blankenstein, S., Rohaan, M., Klop, M., Van der Hiel, B., Van de Wiel, B., Peeper, D., Haanen, J., & van Akkooi, A. (2019). high response rates after neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma, REDUCTOR trial. European journal of surgical oncology, 45(2), e6–. http://access.bl.uk/ark:/81055/vdc_100077367497.0x00002b